ESS vs REPL
Essex Property Trust Inc (ESS) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported ESS revenue for 2024-12-31 was $1.77B. Net income was $811.3M. Revenue was up 6.3% from 2023-12-31 to 2024-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
REPL does not have a complete income-statement cache yet.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. REPL currently screens at market cap $825.7M.
Not investment advice. Open the ESS and REPL stock pages for the full models.
Not investment advice.